Related references
Note: Only part of the references are listed.HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort)
Melina Erica Santos et al.
AIDS AND BEHAVIOR (2020)
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat et al.
LANCET (2019)
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients
Dominique Salmon-Ceron et al.
HEPATOLOGY (2019)
Rates of sustained virological response 12weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
J. Bischoff et al.
HIV MEDICINE (2018)
Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients-ANRS-CO13 HEPAVIH cohort
Oumar Billa et al.
PLOS ONE (2018)
Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy
L. Milazzo et al.
HIV MEDICINE (2017)
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon et al.
GASTROENTEROLOGY (2017)
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study
Karin Neukam et al.
HIV CLINICAL TRIALS (2017)
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
Giuseppe Bruno et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Viral eradication reduces all-cause mortality, including nonliver-related disease, in patients with progressive hepatitis C virus-related fibrosis
Toshifumi Tada et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
Chang Seok Bang et al.
BMC GASTROENTEROLOGY (2017)
Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study
Lars I. Gjaerde et al.
CLINICAL INFECTIOUS DISEASES (2016)
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population
Savino Bruno et al.
JOURNAL OF HEPATOLOGY (2016)
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
Lucy Platt et al.
LANCET INFECTIOUS DISEASES (2016)
Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients
Dominique Salmon et al.
AIDS (2015)
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson et al.
HEPATOLOGY (2015)
Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010
Robert D. Allison et al.
JOURNAL OF HEPATOLOGY (2015)
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Susanna Naggie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Natural history of hepatitis C
Rachel H. Westbrook et al.
JOURNAL OF HEPATOLOGY (2014)
Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk
Alvaro H. Borges et al.
CURRENT OPINION IN HIV AND AIDS (2014)
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers
Alvaro H. Borges et al.
AIDS (2013)
Trends and Predictors of Non-AIDS-Defining Cancers in Men and Women With HIV Infection: A Single-Institution Retrospective Study Before and After the Introduction of HAART
Marco Franzetti et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort
Marc-Arthur Loko et al.
ANTIVIRAL THERAPY (2012)
Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
Mei-Hsuan Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort
Phyllis C. Tien et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
HIV infection and the risk of cancers with and without a known infectious cause
Michael J. Silverberg et al.
AIDS (2009)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection
N Qurishi et al.
LANCET (2003)
Share Paper
